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NMR Nuclear Magnetic Resonance
ESI-MS Electrospray Ionization Mass Spectromatry
UV Ultraviolet
IR Infra-Red
DEPT Distortionless Enhancement by Polarlization Transfer
HSQC Heteronuclear Single-Quantum Coherence
HMBC Heteronuclear Multiple-Bond Correlation
COSY Correlated Spectroscopy
δ chemical shift





dd doublet of doublet
dt doublet of triplet
m multiplet
TLC Thin Layer Chromatography
MPLC Medium Pressure Preparative Liquid Chromatography
Rf Relative mobility
RP-18 Reversed-phase octadecyl silica gel
MTT Methyl Thiazolytetrazolium
PBS Phosphate-Buffered Saline
SDS Sodium Dodecyl Sulfonate














































本论文对 2株马尾松内生真菌拟茎点霉菌 Phomopsis sp. F00164和小丛壳菌
Glomerella sp. F00244以及 1株土壤稀有放线马杜拉菌 Actinomadura sp. x11-7的
次级代谢产物进行了研究，共分离鉴定 25了个化合物，其中 14个为新化合物。
从Phomopsis sp. F00164菌株的固体PDA培养基发酵粗提物中共分离鉴定了
9个化合物，包括 alternariol (F-4)，2个 alternariol衍生物：F-2、F-3；4个 nonenolides
类化合物：F-1、F-35、F-39、F-41；2个 phthalide 衍生物：F-14、F-30。其中
F-1、F-30、F-35、F-39和 F-41为新化合物。
从 Glomerella sp. F00244 菌株的固体 PDA 培养基发酵粗提物中共分离鉴定
了 6个化合物，包括 2个 lanostane 型三萜：H-3、H-8；1个 cerevisterol衍生物
(H-14)，3个 ergosterol类化合物： ergosterol (H-1)，ergosterol peroxide (H-29) 及
其 D环衍生物 (H-17)。其中 H-3、H-8和 H-17为新化合物。
从Actinomadura sp. x11-7菌株的固体YMG培养基发酵粗提物中共分离鉴定
了 10个化合物，包括 2个 pimarane型二萜：Eleven-1、Eleven-3；2个吲哚二聚
体衍生物：Eleven-5、Eleven-6；2个糖苷化合物：Eleven-14、Eleven-17；1个
hydroxylactone 类化合物：Eleven-19； genistein (Eleven-4)；N-acetyltyramine
(Eleven-28)和 cybullol (Eleven-30)。其中 Eleven-1、Eleven-3、Eleven-5、Eleven-6、
Eleven-14和 Eleven-19为新化合物。
对上述化合物的抗肿瘤活性和抗菌活性进行了初步测定。检测结果显示，
Eleven-10 对人宫颈癌 Hela、人肝癌 HepG2 细胞株的 IC50 分别为 11.59、4.70
μg/mL；Eleven-4 对 Hela、HepG2 细胞株的 IC50分别为 54.49、6.84 μg/mL。其


































Bioactive natural products play a highly significant role in the drug discovery
and development process, of which, microbial secondary metabolites take up a large
protion. In recent years，new microbial secondary metabolites were mostly searched
from specific habitat microorganisms of and rare microorganisms, such as plant
endophytes and rare actinomycetes. Due to their specific habitat and genus, they can
produce numerous metabolites with novel and varied skeletons and unique
bioactivities.Furthmore, they can offer novel leads for new drugs.
In this thesis, secondary metabolites from two endophytic fungus and one rare
actinomycete were observed for the discovery of new bioactive compounds.Totally,
twenty-five compounds were isolated and elucidated, including fourteen new
compounds.
Nine compounds were obtained from the agar cultures of the strain Phomopsis sp.
F00164, including, including alternariol (F-4), two alternariol derivatives (F-2, F-3),
four nonenolides (F-1, F-35, F-39, F-41) and two highly substituted phthalides (F-14,
F-30). In which, F-1, F-30, F-35, F-39, F-41 are novel.
Six compounds were isolated from the agar cultures of the strain Glomerella sp.
F00244, including two lanostane-type triterpenes (H-3, H-8), a cerevisterol derivative
(H-14), together with ergosterol (H-1), ergosterol peroxide (EP) (H-29) and a D-ring
derivative of EP (H-17). In which, H-3, H-8, H-17 are novel.
Ten compounds were isolated from the agar cultures of the strain Actinomadura
sp. x11-7, including two pimarane-type diterpenes (Eleven-1, Eleven-3), two
indole-3-carbinol dimer derivatives (Eleven-5, Eleven-6), one hydroxylactones
(Eleven-19), genistein (Eleven-4), N-acetyltyramine (Eleven-28), cybullol
(Eleven-30) and two glycosides derivatives (Eleven-14, Elven-17). In which,
Eleven-1, Eleven-3, Eleven-5, Eleven-6, Elven-14, Eleven-19 are novel.
The chemical structures of all these compounds were elucidated by spectroscopic
and mass spectrometric analysis,including 1D-, 2D-NMR and ESI-MS.
None of these compounds showed obvious antimicrobial activity against
Staphlococus aureus, Micrococcus luteus, Bacillus subtilis, Bacillus pumilus,
Aspergillus niger and Candida Albicans by inhibition zone assay.















MTT assay, with IC50 values of 11.59、4.70 μg/mL, respectively.Meanwhile, Eleven-4
also showed cytotoxic activity in vitro against Hela and HepG2 cell line with IC50
values of 54.49、6.84 μg/mL. Other compounds didn’t show obvious cytotoxic activity
against either of two cell lines.
Our results indicated that plant endophytes and rare actinomycetes can produce
novel metabolites. They are important sources of searching leads for new drugs.























图 1. 1 1981-2002期间所有新药来源分类 (N=1031)
Figure 1. 1 All new chemical entities, 1981-2002, by source (N=1031) (From
Newman, 2003)
(“B”: Biological; usually a large (> 45 residues) peptide or protein either isolated from an organism/cell line
or produced by biotechnological means in a surrogate host. “N”: Natural product. “ND”: Derived from a natural
product and is usually a semisynthetic modification. “S”: Totally synthetic drug, often found by random
screening/modification of an existing agent. “S*”: Made by total synthesis, but the pharmacophore is/was from a
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